Latest news
Loading news…
Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biosimilars and complex peptide-based medicines.
Kashiv BioSciences was acquired by Amneal Pharmaceuticals in 2026 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Piscataway, New Jersey, United States
Acquisitions by Kashiv BioSciences
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Kashiv BioSciences
Executive Chairman and Co-Founder
Global Chief Operating Officer
CLO
Chief Executive Officer
Executive Chairman and Co-Founder
CFO
Senior Vice President of Regulatory Affairs
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kashiv BioSciences
Loading news…
FAQs about Kashiv BioSciences
People who checked this page also checked these
Sectors Kashiv BioSciences invests & acquires in
Browse the full Acquirezy directory.